Aureka Opens Its Drug Discovery Model as AI Biotech Moves Toward Lab-Linked Systems

Why the rise of open source AI isn’t hurting Anthropic … yet

OpenAI Chairman Bret Taylor Compares Current AI Boom to Dotcom Era

Bret Taylor, CEO of AI startup Sierra and chairman of OpenAI, discusses the current AI boom in comparison to the dotcom era, drawing from hi

NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Accelerate Drug Discovery

NVIDIA and Eli Lilly have launched an AI co-innovation lab in the San Francisco Bay Area, committing up to $1 billion over five years to acc

OpenAI and Anthropic CEOs Sign Joint Letter Warning Against AI-Assisted Bioweapons

Rival AI CEOs Sam Altman (OpenAI) and Dario Amodei (Anthropic) have signed an open letter warning against the potential misuse of AI for cre

AI CEOs from OpenAI, Anthropic, and Microsoft jointly urge Congress to mandate synthetic DNA screening to prevent AI-enabled bioweapon creation

CEOs of major AI companies—Dario Amodei (Anthropic), Sam Altman (OpenAI), and Mustafa Suleyman (Microsoft AI)—have co-signed an open letter

AI CEOs from OpenAI, Anthropic, and Microsoft jointly urge Congress to regulate synthetic DNA sales over bioweapon risks

CEOs of major AI companies—Dario Amodei (Anthropic), Sam Altman (OpenAI), and Mustafa Suleyman (Microsoft AI)—have co-signed an open letter